Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2954
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, Anne | en |
dc.contributor.author | Kynaston, J. A. | en |
dc.contributor.author | Kew, K. M. | en |
dc.contributor.author | Petsky, H. L. | en |
dc.contributor.author | Turner, C. | en |
dc.date.accessioned | 2022-11-07T23:37:00Z | - |
dc.date.available | 2022-11-07T23:37:00Z | - |
dc.date.issued | 2015 | en |
dc.identifier.citation | 2015, (1), 2015 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/2954 | - |
dc.description.abstract | This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy of tailoring asthma medications based on exhaled nitric oxide (FeNO) for asthma related outcomes in children. We will compare this with not using FeNO i.e. management based on clinical symptoms (with or without spirometry/peak flow) and/or asthma guidelines.L6205615762018-02-16 <br />2022-07-19 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Cochrane Database of Systematic Reviews | en |
dc.title | Exhaled nitric oxide levels to guide treatment for children with asthma | en |
dc.type | Article | en |
dc.identifier.doi | 10.1002/14651858.CD011439 | en |
dc.subject.keywords | clinical protocol | en |
dc.subject.keywords | disease control | en |
dc.subject.keywords | disease exacerbation | en |
dc.subject.keywords | follow up | en |
dc.subject.keywords | forced expiratory volume | en |
dc.subject.keywords | fractional exhaled nitric oxide | en |
dc.subject.keywords | hospitalization | en |
dc.subject.keywords | human | en |
dc.subject.keywords | outcome assessment | en |
dc.subject.keywords | asthma | en |
dc.subject.keywords | priority journal | en |
dc.subject.keywords | quality of life | en |
dc.subject.keywords | spirometry | en |
dc.subject.keywords | systematic review | en |
dc.subject.keywords | treatment planning | en |
dc.subject.keywords | corticosteroidarticle | en |
dc.subject.keywords | peak expiratory flow | en |
dc.subject.keywords | child health | en |
dc.subject.keywords | clinical effectiveness | en |
dc.subject.keywords | clinical evaluation | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L620561576&from=exporthttp://dx.doi.org/10.1002/14651858.CD011439 | | en |
dc.identifier.risid | 1368 | en |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Sites: | Children's Health Queensland Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.